comparemela.com

Latest Breaking News On - Cabotegravir - Page 2 : comparemela.com

A Promising New Way to Prevent HIV Infections

Why a new injectable drug is a breakthrough, and how Canadian scientists are improving access to it.

United statesUnited kingdomBritish columbiaMichael montessUniversity of victoriaPublic health agency of canadaDrug administrationHealth canadaResearch centreCanadian institutes of health researchBritish columbia ledCanadian institutesHealth researchPublic health agencyCommunity based research centreCanadian hiv medicine

Aspen urges ViiV to licence injectable HIV drug to African generic manufacturers

Debate about cabotegravir picked up after Sahpra announced it had registered the drug

United kingdomWestern capeSouth africaAspen pharmacareFrancois venterStavros nicolaouYogan pillayStellenbosch university departmentSa health products regulatory authority sahpraViiv healthcareProducts regulatory authorityMedicines patent poolStellenbosch universitySaharan africanSub saharan africanSouth african health products regulatory authority

Zimbabwe Scores Another First Against HIV In Africa

Zimbabwe became to first African country to approve the use of the injectable HIV prevention drug called cabotegravir

United statesMashonaland eastFarai masekelaNyaradzo mgodiMedicines control authority of zimbabweWorld health organizationUniversity of zimbabwe clinical trials research centerMedicines control authorityZimbabwe clinical trials research centerHiv prevention

Injections Against HIV Could Be Manufactured Locally and Cheaply, Says Aspen Pharmacare

Cabotegravir is still unaffordable after two years In 2020, pharmaceutical company ViiV Healthcare announced that a bimonthly injection of its new drug, cabotegravir, prevents HIV infection. More than. | December 1, 2022

South africaUnited statesUnited kingdomEastern capeSouth africanAspen pharmacareFrancois venterAndy grayJuliet houghtonStavros nicolaouAndrew hillYogan pillayUniversity of kwazuluClinton health access initiativeAfrican health products regulatory authorityDepartment of pharmacology

New injection could boost HIV fight, but hurdles linger

While the world has focused on the Covid-19 pandemic for nearly three years, less and less attention is being paid to HIV.

United statesSouth africaUnited nationsSaharan africaSouth americaCab la

vimarsana © 2020. All Rights Reserved.